ESR1 and breast neoplasm: It is a heterogeneous disease classified into different molecular subtypes based on the presence (+) or absence (-) of immunohistochemical markers such as ER (estrogen receptor), PR (progesterone receptor), and HER2/neu (human epidermal growth factor receptor 2) in the breast tumour.